Pharmaceutical Technology

MARCH 1, 2023

The Covid-19 pandemic led to massive developments and scientific advances within the field of messenger ribonucleic acid (mRNA) vaccines. Further, the acceptance of new mRNA vaccines has rejuvenated activity within previously established categories of RNA therapeutics including lifesaving antisense technologies.

Vaccines 59

Vaccines Drug Development Diabetes 59

pharmaphorum

MAY 18, 2022

The first edition of the guide has been prepared after a two-year consultation process with organisations involved in digital health, including payors, clinicians, and manufacturers. It aims to provide a harmonised approach that can be deployed regardless of how the product is intended to be used, or the therapeutic category it targets.

85

85

European Pharmaceutical Review

DECEMBER 1, 2023

This interview explores the innovations in biologics delivery, as well as the emergence of new modalities and the shift to continuous manufacturing. There is definitely an interest in advanced therapies, such as cell and gene therapy, plasmids, mRNA, and viral vectors. What are the trends affecting drug development today?

Drug Development 83

Drug Development Dosage Diabetes Process Improvement 83

Quality Matters

AUGUST 22, 2023

The update from FDA provides drug manufacturers and applicants with a recommended framework for a risk-based safety assessment of nitrosamine drug substance-related impurities (NDSRIs) that could be present in products already on the market, as well as in products under development and/or review by the agency. ng/day to 1500 ng/day.

Compounding 98

Compounding 98

European Pharmaceutical Review

FEBRUARY 21, 2023

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. Advising companies, he emphasised that those “manufacturing cannabis-based medicines should not underestimate the scale of the challenge.” Number two is manufacturing APIs consistently. It really comes down to a number of factors.

Pharmaceutical Companies 128

Pharmaceutical Companies Pharmaceutical Companies Compounding Drug Development 128

Pharma Marketing Network

MARCH 14, 2023

Following are excerpts from the report drawing distinctions among representative countries, industry sectors, company size, business functions, and job categories: 12 out of 19 countries have seen the gap increase since 2020, with Greece having the highest increase (six percent) pushing the gap to an alarming 33.7

Communication 52

Communication 52

European Pharmaceutical Review

DECEMBER 22, 2022

The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.

Immunity 105

Immunity Immunization Vaccines Hospitals 105

FDA Law Blog: Biosimilars

JUNE 22, 2023

Though there has been a large number of OTC IVD clearances and decades of experience reviewing OTC IVDs, the bulk of OTC IVD clearances fall in just a few categories, such as pregnancy tests, drugs of abuse tests, and glucose monitoring devices. In the intervening decades, FDA has cleared approximately 1,200 OTC IVDs.

Labelling 59

Labelling Hospitals 59

pharmaphorum

OCTOBER 18, 2022

The agreement will see Biocorp’s Injay device incorporated in UltraSafePlus prefilled syringes, giving them digital connectivity that can be used to gather information such as injection completed, time and date, type of drug, batch number and expiration date – al coded by the manufacturer when the syringe is assembled.

Communication 52

Communication 52

Pharmaceutical Technology

MAY 2, 2023

Despite the significant advances that have been made in the IO field, a huge level of unmet need remains. The unmet needs can be grouped into the broad categories of efficacy-related needs, cost-related needs, toxicity-related needs, personalised care-related needs, and “other” needs.

Immunity 52

Immunity Immunization Vaccines 52

ID Stewardship

APRIL 14, 2024

Recent advancements in FMT methodology have yielded less invasive forms of administration. Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications. Am J Gastroenterol. Jain N, Umar TP, Fahner AF, Gibietis V. Gut Microbes. Wilcox MH.

Hospitals 129

Hospitals Communication 129

Drug Channels

MAY 9, 2022

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hub providers and more for unrivaled collaboration to leverage innovation and optimize access. Offer applies to current rates only and may not be combined with other offers, category rates, promotions or applied to an existing registration.

Specialty Pharmacies 68

Specialty Pharmacies 68

Quality Matters

AUGUST 23, 2023

The update from FDA provides drug manufacturers and applicants with a recommended framework for a risk-based safety assessment of nitrosamine drug substance-related impurities (NDSRIs) that could be present in products already on the market, as well as in products under development and/or review by the agency. ng/day to 1500 ng/day.

Compounding 52

Compounding 52

Putting Patients First Blog

MAY 22, 2023

This includes whether it represents a therapeutic advance; prescribing information; comparative effectiveness, including effects on specific populations; and whether it addresses an unmet need. In addition, we recommend that the guidance include a definition of patient advocacy organization that makes it clear who qualifies in this category.

Drug Pricing 40

Drug Pricing Drug Development 40

pharmaphorum

JUNE 23, 2022

Novartis has shouldered its way into the in vivo gene editing category via a deal with US biotech Precision BioSciences, focused on a therapy for sickle cell disease (SCD). billion in potential milestones if the project advances through development and onto the market. billion agreement that started in 2020.

88

88

Pharmaceutical Technology

JULY 29, 2022

Last week, CAMP4 Therapeutics announced the close of a $100 million Series B round , which will be used to advance their regulatory RNA (regRNA)-focused programs. In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs).

98

98

European Pharmaceutical Review

JUNE 27, 2023

difficile in December 2022, the microbiome therapies space in 2023 has continued to see revolutionary developments and continued research advancement. The new proposed directive 1 for medicinal product has introduced a new biological medicine category which will cover microbiome-based therapies. coli strains in the gut”.

Immunity 98

Immunity Immunization Chemotherapy Vaccines 98

Drug Channels

SEPTEMBER 21, 2020

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Drug Channels, or any of its employees.

Specialty Pharmacies 52

Specialty Pharmacies 52

PharmaShots

MAY 10, 2023

Shots: Driven by constant innovation and life-changing technological advances, medical device companies have integrated a holistic approach to diagnosis and therapeutics. The company has divided its business into four segments i.e., Imaging, Diagnostics, Varian, and Advanced Therapies. Braun’s medical device manufacturing plant.

Nursing Homes 40

Nursing Homes Hospitals Physician Offices Diabetes 40

Pharmaceutical Technology

FEBRUARY 24, 2023

Amivantamab is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.

Chemotherapy 40

Chemotherapy Immunity Immunization Hospitals 40

pharmaphorum

NOVEMBER 2, 2021

Indonesia falls into that category as it has a fragmented healthcare system, despite universal access, which is amplified by the geographical hurdles associated with being an archipelago with 275 million people spread across 6,000 islands. That makes it well suited to distribution in countries where healthcare delivery is more challenging.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

DECEMBER 9, 2022

Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing. The company is ranked in the M&A, PRODUCT LAUNCHES and RESEARCH AND DEVELOPMENT categories in the 2022 Pharmaceutical Technology Excellence Rankings. Pharmaceutical Technology Excellence Rankings – The Verdict.

Vaccines 52

Vaccines Biosimilars Compounding Packaging 52

Drug Channels

MAY 10, 2021

Offer may not be combined with other offers, category rates, promotions or applied to an existing registration. Transform Access Strategies with Compelling Discussions Around. Drug Channels readers are eligible for an exclusive savings of 10% off * the current rate by using promo code 21FRADC10 , be sure to reserve your seat today!

40

40

Drug Channels

OCTOBER 12, 2020

As the election nears and with the recent flurry of regulatory activity surrounding drug pricing transparency, bio/pharma manufacturers must continuously stay ahead of the ever-evolving changes. Offer applies to standard rates only and may not be combined with other offers, category rates, promotions or applied to an existing registration.

Drug Pricing 40

Drug Pricing 40

pharmaphorum

SEPTEMBER 9, 2022

The pharmaceutical industry is globalized: generic drugs manufactured at sites in India will be produced using imported materials and be shipped to distributors worldwide, who will coordinate distributing them to retail businesses or pharmacies,” said the whitepaper. Advances in climate intelligence are making this possible.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

Pharmaceutical Technology

APRIL 18, 2023

Johnson & Johnson researches, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. Joseph Health 23 Unlock company profile Merck & Co 22 Unlock company profile EpitoGenesis 20 Unlock company profile Henry M.

Mayo Clinic 59

Mayo Clinic Immunity Immunization Vaccines 59

European Pharmaceutical Review

JUNE 27, 2022

For development purposes, bsAbs can be divided into two distinct categories depending on the presence or absence of the crystallizable fragment (Fc) region. Rapid screening saves time and resources ( Figure 3 ) and allows determination of the optimal combination of conditions to advance into confirmation scaleup and robustness testing.

Compounding 88

Compounding 88

European Pharmaceutical Review

OCTOBER 2, 2023

The Event Planner is a web and app tool that allows you to plan your time at the event in advance, making your time at CPHI Barcelona more effective. At the heart of pharma, we provide the vital connections that will underpin growth in pharma manufacturing in the next few years. CPHI Pharma Awards 2023 Categories 1.

Packaging 97

Packaging 97

pharmaphorum

JULY 29, 2021

The challenge is, drugs in this category are often difficult to administer and very costly. Today, specialty pharmacies are responsible for distributing therapies to the patient on behalf of the manufacturer, so they need a centralised application to support the entire process of patient intake and distribution.

Specialty Pharmacies 111

Specialty Pharmacies Drug Pricing 111

pharmaphorum

JUNE 1, 2021

While counterfeiters often target lifestyle drugs, every medicine is vulnerable to counterfeiting and life-saving medicines are the fastest-growing category. The technology requires no additional manufacturing equipment or processes, which makes it cost-effective and easy to implement. Silica microtaggants.

Online Pharmacies 52

Online Pharmacies Dosage Packaging Pharmaceutical Companies 52

pharmaphorum

APRIL 15, 2021

We have a pipeline of novel therapeutics and technological approaches, advancing a diverse array of candidates, including small molecules, biologics and cell and gene therapies, so a lot of the time we are working where there’s little, or no precedent.”. However, not all of these processes may be sustainable for the future. “If

Labelling 62

Labelling Communication Pharmaceutical Manufacturing Pharmaceutical Companies 62

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Over the same period, similar countries – including Ireland, France, and Germany – have been moving to boosting manufacturing productivity, output, and exports.

Pharmaceutical Manufacturing 110

Pharmaceutical Manufacturing 110

PharmaShots

APRIL 10, 2023

The medication for diabetes is broadly classified, into two categories, the first category deals with orally administered drugs and the second one includes injectable medicines. Diabetes mellitus is an incurable condition, though patients may undergo remission by changing their lifestyle and eating habits.

Diabetes 40

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 40

PharmaShots

FEBRUARY 21, 2023

Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. On Aug’21, Cellectar entered into a commercial manufacturing and supply agreement with Evergreen Theragnostics for Iopofosine I-131. Other radiotherapies under the company's pipeline include Humalutin and Alpha37.

Dosage 56

Dosage Labelling Immunity Immunization 56

Express Pharma

JANUARY 12, 2024

The government of India has been constantly taking several measures to encourage investments in the sector and promote local manufacturing and consumption, keeping cure and prevention in perspective. The time for commencing manufacturing or production was extended to 31 March 2024 by the Finance Act, 2022.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Health Insurance Companies 52

European Pharmaceutical Review

SEPTEMBER 15, 2023

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. To recognise the influx of innovation across the pharmaceutical industry, three new categories are included in this year’s awards. Are you coming to the CPHI Barcelona 2023?

Packaging 111

Packaging Drug Development 111

Pharmaceutical Technology

MAY 24, 2023

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. CGT drugs fall into two major categories: autologous and allogeneic. CGT trials operate with much lower volumes of manufactured final product.

Labelling 98

Labelling 98